984.64
0.79%
+7.68
プレマーケット:
985.10
0.46
+0.05%
なぜRegeneron Pharmaceuticals, Inc.(REGN)の株価が下がっていますか?
2023-06-27:
REGN's stock fell 8.71% following The Food and Drug Administration (FDA)'s rejection of an 8-milligram-dose version of Regeneron Pharmaceuticals' eye drug Eylea.
大文字化:
|
ボリューム (24 時間):